Immunovant, Inc. SEC filings IMVT
Immunovant, Inc. has 648 filings in SEC EDGAR's recent list, going back to Jan 23, 2019. Its latest annual report, Form ARS, was filed on Jul 22, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 3, 2026 (shareholder vote results). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Shareholder vote results
|
Sep 3, 2026 | Sep 2, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Results of operations
|
May 20, 2026 | May 20, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 6, 2026 | Feb 6, 2026 |
| 8-K |
Current report
Other events
|
Dec 12, 2025 | Dec 10, 2025 |
| 8-K |
Current report
Other events
|
Dec 11, 2025 | Dec 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 21, 2025 | Nov 21, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 3, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Aug 28, 2025 | Aug 27, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 29, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Results of operations
|
May 29, 2025 | May 29, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Apr 21, 2025 | Apr 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 19, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 6, 2025 | Feb 6, 2025 |
| 8-K |
Current report
Other events
|
Jan 24, 2025 | Jan 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 14, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 9, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Aug 13, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Results of operations
|
May 29, 2024 | May 29, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2024 | Feb 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2024 | Jan 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 20, 2023 | Dec 20, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 28, 2023 | Nov 28, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 28, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 26, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Aug 23, 2023 | Aug 21, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
May 22, 2023 | May 22, 2023 |
| 8-K |
Current report
Other events
|
Mar 27, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 3, 2023 | Feb 3, 2023 |
| 8-K |
Current report
Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 8, 2022 | Dec 8, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2022 | Nov 4, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 4, 2022 | Oct 3, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 28, 2022 | Sep 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 7, 2022 | Sep 7, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Aug 19, 2022 | Aug 17, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2022 | Aug 5, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jun 8, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 4, 2022 | Feb 4, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2022 | Jan 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2022 | Jan 5, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 30, 2021 | Dec 30, 2021 |
| 8-K |
Current report
Material agreement
|
Nov 23, 2021 | Nov 17, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 17, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2021 | Nov 5, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 27, 2021 | Sep 27, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Sep 15, 2021 | Sep 9, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Aug 2, 2021 | Aug 2, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2021 | Jul 7, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jun 1, 2021 | Jun 1, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 16, 2021 | Feb 16, 2021 |
| 8-K |
Current report
Other events
|
Feb 2, 2021 | Feb 1, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 9, 2020 |
| 8-K |
Current report
Other events
|
Sep 18, 2020 | Sep 18, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 25, 2020 | Aug 25, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Aug 21, 2020 | Aug 19, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2020 | Aug 12, 2020 |
| 8-K |
Current report
Results of operations
|
Jun 29, 2020 | Jun 29, 2020 |
| 8-K |
Current report
Unregistered share sale, Other events
|
May 14, 2020 | May 12, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 30, 2020 | Mar 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Feb 19, 2020 | Feb 18, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2020 | Feb 14, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Results of operations, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change
|
Dec 20, 2019 | Dec 18, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Dec 17, 2019 | Dec 16, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 2, 2019 | Dec 2, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 25, 2019 | Nov 25, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2019 | Nov 13, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2019 | Nov 8, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2019 | Oct 28, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2019 | Oct 11, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 8, 2019 | Oct 8, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 4, 2019 | Oct 3, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 2, 2019 | Sep 29, 2019 |
| 8-K |
Current report
Officer or director change
|
Aug 26, 2019 | Aug 25, 2019 |
| 8-K/A |
Amended current report
Other events
|
May 20, 2019 | May 9, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 15, 2019 | May 9, 2019 |
Showing 85 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IMVT (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1764013
- Former names
- Health Sciences Acquisitions Corp (until Dec 20, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.